Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases
{{output}}
Immune checkpoint inhibitor-combined chemotherapy (chemo-ICI) is a cornerstone treatment for metastatic non-small cell lung cancer (NSCLC) without oncogenic addictions. However, immunotherapy's efficacy in patients with brain metastases remains unclear. This ... ...
